 |
|
|
|
 |
|
|
| Article 1 to 9 out of 9 concerning Massachusetts Institute of Technology (MIT)
|
-
Novel technology opens the door to the understanding of and possible treatments for obesity, diabetes, ageing and cancer
(08 Oct 2008)
Seahorse Bioscience Announces the XF96 Extracellular Flux Analyzer for Cellular Bioenergetics
Seahorse Bioscience announced the release of the first ever analytical instrument for the kinetic measurement of mitochondrial oxygen consumption and cytoplasmic glycolysis in cells in a 96 well microplate. For the past 75 years tools for measuring ...
-
MIT researchers offer glimpse of rare mutant cells
(24 Jul 2008)
Imaging system may help understand origins of cancer
MIT biological engineers have developed a new imaging system that allows them to see cells that have undergone a specific mutation. The work, which could help scientists understand how precancerous mutations arise, marks the first time researchers ...
-
Alnylam and Collaborators at MIT Publish Research on the Discovery of 'Lipidoids'
(02 May 2008)
Novel Class of Lipid-Based Molecules for the Delivery of RNAi Therapeutics
Alnylam Pharmaceuticals, Inc. announced the publication of a new study in Nature Biotechnology by Alnylam scientists and collaborators from the David H. Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology ...
-
Novartis and Massachusetts Institute of Technology (MIT) in new partnership aimed at transforming pharmaceutical manufacturing
(01 Oct 2007)
* Novartis to invest USD 65 million in MIT research to develop new technologies for continuous manufacturing, from chemical synthesis to final product
Novartis and the Massachusetts Institute of Technology have launched a long-term research collaboration aimed at transforming the way pharmaceuticals are produced.The 10-year partnership, known as the Novartis-MIT Center for Continuous ...
-
MIT creates 3-D images of living cell
(15 Aug 2007)
Method is similar to medical CT scans
A new imaging technique developed at MIT has allowed scientists to create the first 3D images of a living cell, using a method similar to the X-ray CT scans doctors use to see inside the body. The technique, described in a paper published in Nature ...
-
Amgen Foundation Launches $25 Million Undergraduate Research Program
(23 Oct 2006)
As part of its mission to advance science education, the Amgen Foundation announced its partnership with 10 universities to provide hundreds of selected undergraduate students an opportunity to engage in a fully funded, hands-on research experience ...
-
MIT material stops bleeding in seconds
(11 Oct 2006)
Work could significantly impact medicine
MIT and Hong Kong University researchers have shown that some simple biodegradable liquids can stop bleeding in wounded rodents within seconds, a development that could significantly impact medicine. When the liquid, composed of peptides, is applied ...
-
Genetic 'roadmap' charts links between drugs and human disease
(04 Oct 2006)
Scientists create public database of 'genomic signatures' for ~160 drugs and use it to reveal potential applications to cancer and other diseases
A research team led by scientists at the Broad Institute of MIT and Harvard announced the development of a new kind of genetic "roadmap" that can connect human diseases with potential drugs to treat them, as well as predict how new drugs work in ...
-
Millenium Biologix Signs Exclusive License Agreement to Enhance ACTES(TM)-C
(01 Sep 2005)
Millenium Biologix Corporation announced that it has entered into an exclusive license agreement with the Massachusetts Institute of Technology ("MIT") for commercialization rights on their patents related to "Use of Growth Factors for Expansion of ...
|
|
|
|
|
Top
